Medical and Pharmaceutical Translation into Arabic: Avoiding Costly Mistakes

Medical and Pharmaceutical Translation into Arabic: Avoiding Costly Mistakes

In medical and pharmaceutical translation, a mistake is not just a quality issue — it can be a patient safety issue. Incorrect dosage instructions, mistranslated contraindications, or imprecise clinical trial documentation can have consequences that extend far beyond a failed localization project.

Arabic is the official language of 22 countries and is spoken by over 400 million people. For pharmaceutical companies, medical device manufacturers, and life sciences organizations expanding into MENA markets, accurate Arabic translation is a regulatory requirement and an ethical imperative.

The Hidden Complexity of Medical Arabic

Modern Standard Arabic vs. Dialectal Arabic Arabic exists in two broad registers: Modern Standard Arabic (MSA), used in formal writing and official documents, and spoken dialects, which vary significantly by region (Egyptian, Gulf, Levantine, Maghrebi, etc.). Medical and pharmaceutical documentation is always produced in MSA — but patient-facing materials like instructions for use or patient information leaflets may benefit from dialect-aware adaptation for specific markets.

Terminology standardization Medical Arabic terminology is not fully standardized across the Arab world. The same anatomical term, drug class, or clinical concept may be rendered differently in Saudi Arabia, Egypt, and the UAE. Working with translators who understand these regional variations — and knowing which standard to apply for which market — is essential.

Regulatory requirements vary by country Regulatory bodies across MENA markets have different requirements for translation of product labels, package inserts, and clinical documentation. SFDA (Saudi Arabia), MOH (UAE), and EDA (Egypt) each have their own submission standards. Our team is familiar with these requirements and ensures translated documents meet local regulatory expectations.

Most Common Mistakes in Medical Arabic Translation

1. Using machine translation without expert post-editing. MT tools perform poorly on medical Arabic. Technical terms are frequently mistranslated, and the output often reads unnaturally to native speakers.

2. Ignoring document formatting standards. Arabic medical documents have specific formatting conventions for package inserts, IFUs, and clinical reports. Delivering a translated .docx with wrong formatting can delay regulatory approval.

3. Skipping back-translation. For clinical trial documents and regulatory submissions, back-translation (translating the Arabic back to English by a different translator) is standard practice and often required. Omitting this step is a red flag.

4. Assigning non-specialist translators. A general translator, even a highly skilled one, should not be translating pharmacovigilance reports or informed consent forms without medical background.

Texel's Life Sciences Translation Process

Our medical and pharmaceutical translation team includes translators with backgrounds in medicine, pharmacy, biology, and clinical research. Every translation in this domain goes through:

• Translation by a subject-matter expert

• Review by a second medical linguist

• Terminology consistency check against approved glossaries

• Formatting review against target-market regulatory standards

We are ISO 17100 certified, and our processes are designed to meet the documentation requirements of major regulatory agencies.

Expanding into MENA markets? Contact Texel to discuss your medical translation needs.